This is a federal contract award from the Defense Logistics Agency Troop Support Medical to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The contract is for the delivery of zanamivir, an antiviral medication, with a potential value of $118,463.40. It is a firm fixed price delivery order contract, with no set-aside designation. Glaxosmithkline has received multiple federal contracts and grants to support disease prevention efforts, immunization programs, drug stockpiling initiatives, and correctional facility healthcare services. This contract is part of a larger portfolio of federal contracts and indefinite delivery vehicles held by Glaxosmithkline, including a $15 million contract with the VA National Acquisition Center to supply seasonal influenza vaccines and a $3 million CDC contract for vaccine storage and rotation services.